RORγ agonist LYC-55716 in combination with pembrolizumab to treat metastatic non-small cell lung cancer: An open-label, multicenter phase Ib trial

Authors :: Shirish M. Gadgeel
H.J. Wilkins
Garry Alan Weems
D.R. Camidge
R. Santana-Davila
Melissa Lynne Johnson
Source :: Annals of Oncology. 29:viii417
Publication Year :: 2018
Publisher :: Elsevier BV, 2018.

Subjects :: 0301 basic medicine
Agonist
medicine.drug_class
business.industry
Hematology
Pembrolizumab
medicine.disease
03 medical and health sciences
030104 developmental biology
0302 clinical medicine
Oncology
030220 oncology & carcinogenesis
medicine
Cancer research
Non small cell
Open label
business
Lung cancer

Tools